Skip to main navigation Skip to search Skip to main content

PTEN loss promotes mitochondrially dependent type II fas-induced apoptosis via PEA-15

  • James W. Peacock
  • , Jodie Palmer
  • , Dieter Fink
  • , Stephen Ip
  • , Eric M. Pietras
  • , Alice L.F. Mui
  • , Stephen W. Chung
  • , Martin E. Gleave
  • , Michael E. Cox
  • , Ramon Parsons
  • , Marcus E. Peter
  • , Christopher J. Ong

Research output: Contribution to journalArticlepeer-review

38 Scopus citations

Abstract

Two distinct biochemical signals are delivered by the CD95/Fas death receptor. The molecular basis for the differential mitochondrially independent (type I) and mitochondrially dependent (type II) Fas apoptosis pathways is unknown. By analyzing 24 Fas-sensitive tumor lines, we now demonstrate that expression/activity of the PTEN tumor suppressor strongly correlates with the distinct Fas signals. PTEN loss-of-function and gain-of-function studies demonstrate the ability to interconvert between type I and type II Fas pathways. Importantly, from analyses of Bcl-2 transgenic Pten+/- mice, Pten haploinsufficiency converts Fas-induced apoptosis from a Bcl-2-independent to a Bcl-2-sensitive response in primary thymocytes and activated T lymphocytes. We further show that PTEN influences Fas signaling, at least in part, by regulating PEA-15 phosphorylation and activity that, in turn, regulate the ability of Bcl-2 to suppress Fas-induced apoptosis. Thus, PTEN is a key molecular rheostat that determines whether a cell dies by a mitochondrially independent type I versus a mitochondrially dependent type II apoptotic pathway upon Fas stimulation.

Original languageEnglish
Pages (from-to)1222-1234
Number of pages13
JournalMolecular and Cellular Biology
Volume29
Issue number5
DOIs
StatePublished - Mar 2009
Externally publishedYes

Fingerprint

Dive into the research topics of 'PTEN loss promotes mitochondrially dependent type II fas-induced apoptosis via PEA-15'. Together they form a unique fingerprint.

Cite this